Stockhead’s Fraser Palamara sits down with EBR Systems (ASX:EBR)  President and CEO John McCutcheon to get the short end of the long story on the company’s latest news.

The company has reached a major milestone recently when they submitted the final module of its PME application to FDA for its WiSE CRT system. The Submission moves EBR closer to commercialising world-first device in US.

Tune in to hear John discuss just what was required for such a submission and what they have planned once they have FDA approval.

 

This video was developed in collaboration with EBR Systems, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Read MoreMedtech

Featured Companies

You might be interested in